Maria Lysaker-USA TODAY Sports

Houston Texans defensive end Dylan Horton got to share some good news as he heads into his first full offseason as a professional football player: He is in remission. Horton previously announced he was diagnosed with Stage 4 Hodgkin’s Lymphoma.

But since that diagnosis in early December, Horton has been doggedly pursuing a treatment plan. And it’s paid off in a big way.

“On December 1, 2023, I was diagnosed with Stage 4 Hodgkin’s Lymphoma. Though God’s grace, I’m blessed to say that I’m currently in remission,” Horton said in a statement. “I am grateful for the love from my family and friends, and support from the Texans organization and my doctors.”

He vowed a return to the field is imminent.

“The next objective is to complete my treatments, then get back to play the game that I love. Than you for your prayers and support as I continue this journey,” Horton said.

Another Texan returned to the field after a cancer battle in 2023

Houston Texans wide receiver John Metchie touched the ball just four times on Saturday in the team’s win against the Cleveland Browns but his impact was significant. He amassed 44 yards receiving and nine yards rushing as the team put the hurt on the Browns to the tune of a 45-14 final score. The former second-rounder’s career hasn’t gone as he’d expected but his performance in the Wild Card game and beyond this season had head coach DeMeco Ryans singing his praises post-game.

“Metchie’s had up and downs through the season, had some opportunities to make plays and some moments he made them and some he didn’t but what a moment for him this past game to come up with a couple of big catches there,” Ryans said.

“Really proud of him for his journey and all that he’s been through. No one’s been through it tougher than him and for him to show the resolve and to continue to push and fight to get better at his craft, day in and day out, nobody works on their craft harder than Metchie. It’s good to see the success come from it in our first playoff game.”

Metchie missed the entire 2022 season after receiving a diagnosis of Leukemia after the draft. Though he was initially cleared for play on that front this offseason, a hamstring injury set him back leading up to training camp.

Metchie’s cancer diagnosis, which came last July, revealed he had APL (Acute Promyelocytic Leukemia), which is a form of Leukemia with the highest rates of long-term survival. After finding out about his condition, the second-rounder spent a month and a half in in-patient treatment. He followed that up with several months of outpatient chemotherapy.

This season, the former Crimson Tide star had 16 catches for 158 yards in the regular season.

More must-reads:

TODAY'S BEST
Perpetual Bulls trade candidate once more hitting the rumor mill
MLB announces host venues for 2026 World Baseball Classic
Knicks marquee trade acquisition could bolt in free agency
ESPN and long-time NFL reporter are parting ways
If Lions HC Dan Campbell's assessment of WR is accurate it could mean trouble for opponents
NBA closes investigation into embattled Thunder guard
NFL reporter predicts Cowboys' plan for QB Dak Prescott
Cavaliers make decision on head coach J.B. Bickerstaff’s future
Two young stars get hefty bonuses for making All-NBA teams
Mavericks star duo joins exclusive club with Game 1 win
Mavericks ride 'Luka Magic' on both ends late to win Game 1
Panthers shut out Rangers 3-0 in Eastern Conference Final opener
NBA announces 2023-24 All-NBA teams
Star Padres infielder to miss significant time with shoulder injury
LeBron James, Charles Barkley passionately defend Caitlin Clark from 'petty' haters
Roger Goodell discusses factors for possible 18-game NFL season
Cowboys QB Dak Prescott has intriguing comment on his contract situation
Celtics toying around with surprise Jayson Tatum move in conference finals
Former teammate warns Tee Higgins about pitfalls of playing on franchise tag
Watch: Timberwolves and Mavericks trade dunks in third quarter